Earum Pharmaceuticals Ltd
ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD
Stock has been generating better return on equity than bank FD
Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company
Stock doesn't offer attractive dividend returns
Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock
Good time to consider, as stock is not in overbought zone
No Red FlagsASM and GSM lists are measures to safeguard investors against volatility and unjustified stock prices. Pledging holdings means taking loans against held promoter shares. Stocks in ASM/GSM list or with high pledged promoter holding should be handled with caution. Unsolicited tips are sometimes circulated to manipulate the market. Beware of these stocks
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
Standalone
Financial Statements
Income
Balance Sheet
Cash Flow
What is an income statement?
The income statement indicates a company's financial performance measured over a reporting period. Performance is assessed by summarising how the business incurs its revenues, expenses and net profit or loss incurred over the period. It's also called the P&L statement
Income Statement
Lower than Industry Revenue GrowthA higher-than-industry revenue growth represents increased potential for the company to increase their market share
Over the last 5 years, revenue has grown at a yearly rate of 3.94%, vs industry avg of 8.73%
Constant Market ShareMarket share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors
Over the last 5 years, market share stayed at 0.01%
Higher than Industry Net IncomeNet income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is
Over the last 5 years, net income has grown at a yearly rate of 69.22%, vs industry avg of 8.5%
| Financial Year | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 8.84 | 18.63 | 23.69 | 35.85 | 50.75 | 57.38 | 50.01 | 28.74 |
Raw Materials | 0.00 | 0.00 | 9.14 | 19.04 | 24.94 | 34.93 | 48.87 | 52.82 | 48.34 | 21.83 |
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.04 | 0.01 | 0.02 |
| Employee Cost | 0.00 | 0.00 | 0.27 | 0.40 | 0.30 | 0.10 | 0.19 | 0.30 | 0.29 | 0.04 |
| Selling & Administrative Expenses | 0.00 | 0.00 | 0.62 | 0.66 | 0.49 | 0.52 | 0.90 | 2.88 | 2.25 | 0.34 |
| Operating & Other expenses | 0.00 | 0.00 | -1.42 | -2.04 | -2.83 | -1.70 | -2.58 | -2.17 | -2.05 | 3.23 |
EBITDA | 0.00 | 0.00 | 0.23 | 0.57 | 0.78 | 1.98 | 3.35 | 3.51 | 1.17 | 3.28 |
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.02 | 0.04 | 0.10 | 0.12 | 0.12 |
| PBIT | 0.00 | 0.00 | 0.23 | 0.55 | 0.76 | 1.96 | 3.31 | 3.41 | 1.05 | 3.16 |
| Interest & Other Items | 0.00 | 0.00 | 0.06 | 0.39 | 0.52 | 0.72 | 1.04 | 0.97 | 0.93 | 0.08 |
| PBT | 0.00 | 0.00 | 0.17 | 0.16 | 0.24 | 1.24 | 2.27 | 2.44 | 0.12 | 3.08 |
| Taxes & Other Items | 0.00 | 0.00 | 0.05 | 0.07 | 0.08 | 0.33 | 0.62 | 0.63 | 0.03 | 0.86 |
| Net Income | 0.00 | 0.00 | 0.12 | 0.09 | 0.16 | 0.91 | 1.65 | 1.81 | 0.09 | 2.22 |
| EPS | 0.00 | 0.00 | 0.09 | 0.01 | 0.01 | 0.03 | 0.04 | 0.07 | 0.01 | 0.36 |
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payout ratio | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data